Immune-Mediated Thrombocytopenia in Dogs: Advanced Guide
An in-depth guide to IMTP in dogs, covering diagnosis, welfare impacts, treatment options, and long-term management.
Key Facts
IMTP involves the immune system destroying platelets causing bleeding risk
Petechiae (pinpoint haemorrhages), bruising, and nosebleeds are common signs
Life-threatening internal bleeding can occur without warning
Treatment with immunosuppressive drugs is usually effective
Vincristine can rapidly increase platelet counts in severe cases
Long-term prognosis is generally good with appropriate management
Welfare Considerations and Management
Welfare-centred IMTP management requires rapid diagnosis and prompt immunosuppression. Prednisolone is the first-line treatment; azathioprine, cyclosporin, or mycophenolate are added for refractory cases. Dogs with platelet counts below 20,000/µl require strict cage rest to reduce bleeding risk. Human intravenous immunoglobulin (hIVIG) provides rapid platelet stabilisation in severe cases. Transfusions support dogs with severe anaemia. Long-term monitoring prevents relapse.
What You Can Do
Restrict activity strictly when platelet counts are critically low
Administer all immunosuppressive medications as directed by your vet
Monitor for signs of internal bleeding (sudden weakness, pale gums)
Regular blood count monitoring guides treatment adjustments and tapering